A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
Public ClinicalTrials.gov record NCT03878446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or Norditropin® - which treatment is decided by chance. Both participants and the study doctor will know which treatment the participants get. The study will last for 5 years. Participants will take either an injection once every week or once every day.
Study identification
- NCT ID
- NCT03878446
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 62 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 2 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 4, 2019 (Actual)
- Primary completion
- May 5, 2021 (Actual)
- Completion
- Dec 23, 2026 (Estimated)
- Last update posted
- Oct 6, 2026
2019 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of AL at Birmingham_BRM | Birmingham | Alabama | 35233 | — |
| Children's Hosp Of Orange | Orange | California | 92868 | — |
| St. Luke's Children's Endo | Boise | Idaho | 83712 | — |
| Univ of Minnesota M.C.H. | Minneapolis | Minnesota | 55454 | — |
| Children's Minnesota | Saint Paul | Minnesota | 55102 | — |
| Goryeb Children's Hospital | Morristown | New Jersey | 07962 | — |
| Rutgers-Rwjms | New Brunswick | New Jersey | 08901 | — |
| NYU Langone Hospital-LI | Garden City | New York | 11530 | — |
| NYU Langone Hospital-LI | Mineola | New York | 11501 | — |
| Icahn Sch of Med-Mt Sinai Hosp | New York | New York | 10029 | — |
| CCHMC_Cinc | Cincinnati | Ohio | 45229 | — |
| Univ Oklahoma Sci Ctr OK City | Oklahoma City | Oklahoma | 73104 | — |
| Cook Children's Hospital-Hematology-Oncology | Fort Worth | Texas | 76104 | — |
| MultiCare Inst for Res & Innov | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03878446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03878446 live on ClinicalTrials.gov.